Valion Bio Inc Sustainability Reports
Valion Bio, Inc. operates as a late-stage biopharmaceutical company focused on immunotherapy developments, biodefense platforms, and domestic contract development and manufacturing operations through its subsidiary Velocity Bioworks.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300220ZCYIY888U96
FIGI: BBG00PT2YC13
4 reports from 2021 to 2025